Inventor
SZELAGIEWICZ MARTIN
CH39 patents
⚠️ This page may combine multiple inventors who share the name “SZELAGIEWICZ MARTIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERCK PATENT GMBH
9 patentsUS11992491B2May 28, 2024
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and L-valine ethyl ester
MERCK PATENT GMBH2 citations72
US11925644B2Mar 12, 2024
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and l-leucine ethyl ester
MERCK PATENT GMBH2 citations72
US12221446B2Feb 11, 2025
Crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester
MERCK PATENT GMBH0 citations62
US12221445B2Feb 11, 2025
Crystalline salts of 5-methyl-(6S)-tetrahydrofolic acid and amino ethyl esters
MERCK PATENT GMBH0 citations62
US11633400B2Apr 25, 2023
Crystalline salt comprising 5-methyl-(6S)-tetrahydrofolic acid and 4-(2-hydroxyethyl)-morpholine
MERCK PATENT GMBH0 citations62
US11377448B2Jul 5, 2022
Crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid
MERCK PATENT GMBH0 citations60
US12048700B2Jul 30, 2024
Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid
MERCK PATENT GMBH0 citations59
US11185545B2Nov 30, 2021
Crystalline monosodium salt of 5-methyl-(6S)-tetrahydrofolic acid
MERCK PATENT GMBH0 citations59
US11066408B2Jul 20, 2021
Crystalline binary sodium salts of 5-methyl-(6S)-tetrahydrofolic acid with organic bases
MERCK PATENT GMBH0 citations59
BASF SE
8 patentsUS9884857B2Feb 6, 2018
Salts of dasatinib in amorphous form
BASF SE19 citations93
US9556164B2Jan 31, 2017
Salts of Dasatinib in crystalline form
BASF SE8 citations83
US9340536B2May 17, 2016
Multicomponent crystals comprising dasatinib and selected co-crystal formers
BASF SE8 citations83
US9567317B2Feb 14, 2017
Multicomponent crystalline system comprising nilotinib and selected co-crystal formers
BASF SE6 citations82
US7932387B2Apr 26, 2011
Crystalline forms of rosuvastatin calcium salt
BASF SE3 citations63
US8841316B2Sep 23, 2014
Multicomponent crystalline system of rosuvastatin calcium salt and vanillin
BASF SE3 citations62
US9290452B2Mar 22, 2016
Multicomponent crystalline system comprising deferasirox and isonicotinamide and a process for the preparation thereof
BASF SE2 citations61
US10045998B2Aug 14, 2018
Solid form of abiraterone acetate
BASF SE0 citations51
CIBA SC HOLDING AG
7 patentsUS6696479B2Feb 24, 2004
Crystalline forms
CIBA SC HOLDING AG31 citations92
US6939992B2Sep 6, 2005
Polymorphic forms of sertraline hydrochloride
CIBA SC HOLDING AG18 citations91
US6872853B1Mar 29, 2005
Polymorphic forms of sertraline hydrochloride
CIBA SC HOLDING AG17 citations89
US7442838B2Oct 28, 2008
Polymorphic forms of sertraline hydrochloride
CIBA SC HOLDING AG12 citations83
US6858643B2Feb 22, 2005
Crystalline forms of Fluvastatin sodium
CIBA SC HOLDING AG7 citations73
US7432380B2Oct 7, 2008
Crystalline form of Fluvastatin sodium
CIBA SC HOLDING AG4 citations63
US7045661B2May 16, 2006
Crystalline forms of venlafaxine hydrochloride
CIBA SC HOLDING AG2 citations61
NOVARTIS AG
3 patentsUS6455556B2Sep 24, 2002
Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
NOVARTIS AG10 citations71
US6740669B1May 25, 2004
Crystal modification of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and its use as antiepileptic
NOVARTIS AG3 citations60
US7750028B2Jul 6, 2010
Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1, 2,3-triazole-4-carboxamide
NOVARTIS AG0 citations47